Jubilant Pharma Acquires US Radiopharmacy Business Of Triad Isotopes

This acquisition is funded through JPL’s internal accruals with no increase in debt for Jubilant Life Sciences Ltd
Source: Today Deals

Leave a Reply

Your email address will not be published. Required fields are marked *